Consolidated Portfolio Review Corp Dexcom Inc Transaction History
Consolidated Portfolio Review Corp
- $381 Billion
- Q1 2024
A detailed history of Consolidated Portfolio Review Corp transactions in Dexcom Inc stock. As of the latest transaction made, Consolidated Portfolio Review Corp holds 2,813 shares of DXCM stock, worth $314,099. This represents 0.1% of its overall portfolio holdings.
Number of Shares
2,813
Previous 2,608
7.86%
Holding current value
$314,099
Previous $324 Million
20.56%
% of portfolio
0.1%
Previous 0.07%
Shares
4 transactions
Others Institutions Holding DXCM
# of Institutions
1,124Shares Held
353MCall Options Held
4.19MPut Options Held
4.54M-
Vanguard Group Inc Valley Forge, PA44.6MShares$4.98 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY33.9MShares$3.79 Billion0.11% of portfolio
-
State Street Corp Boston, MA16.2MShares$1.81 Billion0.1% of portfolio
-
Baillie Gifford & CO15.7MShares$1.75 Billion1.72% of portfolio
-
Capital Research Global Investors Los Angeles, CA13.4MShares$1.5 Billion0.43% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $43.1B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...